ERBB2 and breast cancer: It accounts for 31% of all incident cases and 15% of all deaths in females.[1] The current treatment approach for breast cancer involves surgical resection combined with radiation therapy, anti-human epidermal growth factor receptor 2 (HER2) therapy, and endocrine therapy.